2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Sarcoma, Soft Tissue: new trials by email Literature Review of Sarcoma, Soft Tissue trials Research Report on Sarcoma, Soft Tissue
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ph II Nintedanib vs. Ifosfamide in Soft Tissue Sarcoma Nintedanib, Ifosfamide - Sarcoma, Soft Tissue | Phase 2 | Terminated | European Organisation for Research and Treatment of Cancer - EORTC | 80 | 2017-07-07 | 2021-09-20 |
| Sunitinib in Certain Subtypes of Soft Tissue Sarcomas Sunitinib - Sarcoma, Soft Tissue | Phase 2 | Terminated | Columbia University | 10 | 2007-04-01 | 2019-11-04 |
Sarcoma (2)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Connective and Soft Tissue (2)
Ifosfamide (1) · Sunitinib (1) · nintedanib (1)
Columbia University (1) · European Organisation for Research and Treatment of Cancer - EORTC (1)
Belgium (1) · France (1) · Lithuania (1) · Netherlands (1) · Poland (1) · Spain (1) · United Kingdom (1) · United States (1)
Patrick Schoeffski, MD (1) · Robert N Taub, MD, PhD (1)
2016 (1)